AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CETUXIMAB

14 registrations across 8 African markets— 12 active

Markets with CETUXIMAB

Recent registrations

Brand / ProductMarketHolderStatusExpires
Erbitux 5 mg/ml (20 ml)
Solution for Injection
🇿🇲ZambiaMerck (Pty) LtdactiveJan 2031
Erbitux Solution for Infusion**
Solution for infusion
🇳🇬NigeriaMerck Pharmaceutical and Life Sciences LimitedactiveFeb 2028
ERBITUX 100
Solution injectable pour perfusion / 5 mg/ml
🇹🇳TunisiaMERCK KgaAexpiredMay 2012
ERBITUX 500
Solution injectable pour perfusion / 5 mg/ml
🇹🇳TunisiaMERCK KgaAexpiredMay 2012
ERBITUX 5 mg/ml🇿🇦South AfricaMerck (Pty) LtdactiveJan 1900
CETUXIMAB
PARENTERAL ORDINARY INFUSION VIALS/BOTTLES
🇺🇬UgandaMERCK (PTY) LTDactive
ERBITUX 5MG/ML IV SOLUTION POUR PERFUSION FLACON DE 20ML🇨🇮Côte d'IvoireMERCK EUROPE B.V.active
Erbitux
Solution For Infussion
🇹🇿TanzaniaMerck (Pty) Ltdactive
ERBITUX 5 MG/ML
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
ERBITUX 5 MG/ML
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
CETUXIMAB
PARENTERAL ORDINARY INFUSION VIALS/BOTTLES
🇺🇬UgandaMERCK (PTY) LTDactive
ERBITUX 5 MG/ML
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
ERBITUX 5 MG/ML
SOLUTION POUR PERFUSION
🇲🇦Moroccoactive
Erbitux
Solution For Infussion
🇹🇿TanzaniaMerck (Pty) Ltdactive

CETUXIMAB in Africa — Regulatory Overview

CETUXIMAB is registered across 8 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tanzania, Uganda, Tunisia and 4 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 14 registrations, 12 (86%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.